270 related articles for article (PubMed ID: 27807633)
21. The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer.
Lewis BC; Klimstra DS; Varmus HE
Genes Dev; 2003 Dec; 17(24):3127-38. PubMed ID: 14681205
[TBL] [Abstract][Full Text] [Related]
22. BCL10 as a useful marker for pancreatic acinar cell carcinoma, especially using endoscopic ultrasound cytology specimens.
Hosoda W; Sasaki E; Murakami Y; Yamao K; Shimizu Y; Yatabe Y
Pathol Int; 2013 Mar; 63(3):176-82. PubMed ID: 23530562
[TBL] [Abstract][Full Text] [Related]
23. Up-regulation of L1CAM in pancreatic duct cells is transforming growth factor beta1- and slug-dependent: role in malignant transformation of pancreatic cancer.
Geismann C; Morscheck M; Koch D; Bergmann F; Ungefroren H; Arlt A; Tsao MS; Bachem MG; Altevogt P; Sipos B; Fölsch UR; Schäfer H; Müerköster SS
Cancer Res; 2009 May; 69(10):4517-26. PubMed ID: 19435915
[TBL] [Abstract][Full Text] [Related]
24. Whole-exome sequencing of pancreatic neoplasms with acinar differentiation.
Jiao Y; Yonescu R; Offerhaus GJ; Klimstra DS; Maitra A; Eshleman JR; Herman JG; Poh W; Pelosof L; Wolfgang CL; Vogelstein B; Kinzler KW; Hruban RH; Papadopoulos N; Wood LD
J Pathol; 2014 Mar; 232(4):428-35. PubMed ID: 24293293
[TBL] [Abstract][Full Text] [Related]
25. Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant Kras in transgenic mice.
Grippo PJ; Nowlin PS; Demeure MJ; Longnecker DS; Sandgren EP
Cancer Res; 2003 May; 63(9):2016-9. PubMed ID: 12727811
[TBL] [Abstract][Full Text] [Related]
26. Ductal origin of pancreatic adenocarcinomas induced by conditional activation of a human Ha-ras oncogene in rat pancreas.
Ueda S; Fukamachi K; Matsuoka Y; Takasuka N; Takeshita F; Naito A; Iigo M; Alexander DB; Moore MA; Saito I; Ochiya T; Tsuda H
Carcinogenesis; 2006 Dec; 27(12):2497-510. PubMed ID: 16774944
[TBL] [Abstract][Full Text] [Related]
27. Prox1-Heterozygosis Sensitizes the Pancreas to Oncogenic Kras-Induced Neoplastic Transformation.
Drosos Y; Neale G; Ye J; Paul L; Kuliyev E; Maitra A; Means AL; Washington MK; Rehg J; Finkelstein DB; Sosa-Pineda B
Neoplasia; 2016 Mar; 18(3):172-84. PubMed ID: 26992918
[TBL] [Abstract][Full Text] [Related]
28. Commitment and oncogene-induced plasticity of human stem cell-derived pancreatic acinar and ductal organoids.
Huang L; Desai R; Conrad DN; Leite NC; Akshinthala D; Lim CM; Gonzalez R; Muthuswamy LB; Gartner Z; Muthuswamy SK
Cell Stem Cell; 2021 Jun; 28(6):1090-1104.e6. PubMed ID: 33915081
[TBL] [Abstract][Full Text] [Related]
29. Inactivation of TGFβ receptor II signalling in pancreatic epithelial cells promotes acinar cell proliferation, acinar-to-ductal metaplasia and fibrosis during pancreatitis.
Grabliauskaite K; Saponara E; Reding T; Bombardo M; Seleznik GM; Malagola E; Zabel A; Faso C; Sonda S; Graf R
J Pathol; 2016 Feb; 238(3):434-45. PubMed ID: 26510396
[TBL] [Abstract][Full Text] [Related]
30. Genome-wide genetic and epigenetic analyses of pancreatic acinar cell carcinomas reveal aberrations in genome stability.
Jäkel C; Bergmann F; Toth R; Assenov Y; van der Duin D; Strobel O; Hank T; Klöppel G; Dorrell C; Grompe M; Moss J; Dor Y; Schirmacher P; Plass C; Popanda O; Schmezer P
Nat Commun; 2017 Nov; 8(1):1323. PubMed ID: 29109526
[TBL] [Abstract][Full Text] [Related]
31. Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.
Qiu W; Tang SM; Lee S; Turk AT; Sireci AN; Qiu A; Rose C; Xie C; Kitajewski J; Wen HJ; Crawford HC; Sims PA; Hruban RH; Remotti HE; Su GH
Gastroenterology; 2016 Jan; 150(1):218-228.e12. PubMed ID: 26408346
[TBL] [Abstract][Full Text] [Related]
32. Ductal and acinar differentiation in pancreatic endocrine tumors.
Kamisawa T; Tu Y; Egawa N; Ishiwata J; Tsuruta K; Okamoto A; Hayashi Y; Koike M; Yamaguchi T
Dig Dis Sci; 2002 Oct; 47(10):2254-61. PubMed ID: 12395898
[TBL] [Abstract][Full Text] [Related]
33. Pathology and genetics of pancreatic neoplasms with acinar differentiation.
Wood LD; Klimstra DS
Semin Diagn Pathol; 2014 Nov; 31(6):491-497. PubMed ID: 25441307
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma.
Vaz AP; Deb S; Rachagani S; Dey P; Muniyan S; Lakshmanan I; Karmakar S; Smith L; Johansson S; Lele S; Ouellette M; Ponnusamy MP; Batra SK
Oncotarget; 2016 Jan; 7(3):3317-31. PubMed ID: 26689992
[TBL] [Abstract][Full Text] [Related]
35. The anti-oxidative transcription factor Nuclear factor E2 related factor-2 (Nrf2) counteracts TGF-β1 mediated growth inhibition of pancreatic ductal epithelial cells -Nrf2 as determinant of pro-tumorigenic functions of TGF-β1.
Genrich G; Kruppa M; Lenk L; Helm O; Broich A; Freitag-Wolf S; Röcken C; Sipos B; Schäfer H; Sebens S
BMC Cancer; 2016 Feb; 16():155. PubMed ID: 26915435
[TBL] [Abstract][Full Text] [Related]
36. The basic helix-loop-helix transcription factor E47 reprograms human pancreatic cancer cells to a quiescent acinar state with reduced tumorigenic potential.
Kim S; Lahmy R; Riha C; Yang C; Jakubison BL; van Niekerk J; Staub C; Wu Y; Gates K; Dong DS; Konieczny SF; Itkin-Ansari P
Pancreas; 2015 Jul; 44(5):718-27. PubMed ID: 25894862
[TBL] [Abstract][Full Text] [Related]
37. Protease-activated receptor 1 drives and maintains ductal cell fates in the premalignant pancreas and ductal adenocarcinoma.
Tekin C; Scicluna BP; Lodestijn SC; Shi K; Bijlsma MF; Spek CA
Mol Oncol; 2021 Nov; 15(11):3091-3108. PubMed ID: 33932087
[TBL] [Abstract][Full Text] [Related]
38. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis.
Moore PS; Orlandini S; Zamboni G; Capelli P; Rigaud G; Falconi M; Bassi C; Lemoine NR; Scarpa A
Br J Cancer; 2001 Jan; 84(2):253-62. PubMed ID: 11161385
[TBL] [Abstract][Full Text] [Related]
39. Early requirement of Rac1 in a mouse model of pancreatic cancer.
Heid I; Lubeseder-Martellato C; Sipos B; Mazur PK; Lesina M; Schmid RM; Siveke JT
Gastroenterology; 2011 Aug; 141(2):719-30, 730.e1-7. PubMed ID: 21684285
[TBL] [Abstract][Full Text] [Related]
40. Tissue plasminogen activator in murine exocrine pancreas cancer: selective expression in ductal tumors and contribution to cancer progression.
Aguilar S; Corominas JM; Malats N; Pereira JA; Dufresne M; Real FX; Navarro P
Am J Pathol; 2004 Oct; 165(4):1129-39. PubMed ID: 15466380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
